V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330013327 | 330003901 | 1.67 | 68.8 | Adjuvant (A) | null | 2017-09-29 | Doxorubicin 75mg/m2 | Y | null | 330007724 | DOXORUBICIN |
| 330013328 | 330008142 | 1.57 | 68 | Palliative (P) | 2015-09-21 | 2015-11-06 | Carboplatin AUC 6 - 10 | N | N | 330007971 | CARBOPLATIN |
| 330013329 | 330004132 | null | 42.7 | Palliative (P) | 2017-01-12 | 2017-01-18 | Docetaxel+Gemcitabine (no prior RT) | N | N | 330009031 | DOCETAXEL + GEMCITABINE |
| 330013330 | 330004162 | 1.24 | null | Palliative (P) | 2017-12-04 | 2018-04-23 | Cytarabine High Dose | 2 | null | 330009184 | CYTARABINE HIGH DOSE |
| 330013331 | 330004305 | 1.65 | null | Curative (C) | 2016-06-21 | 2016-08-09 | KESTREL Trial | null | N | 330011097 | CAPECITABINE + OXALIPLATIN |
| 330013334 | 330005214 | 0 | 66.7 | Disease modification (D) | 2020-03-29 | 2020-04-14 | Cisplatin+Doxorubicin+Etoposide 28d | N | N | 330017874 | SUNITINIB |
| 330013335 | 330005600 | 0 | 77.1 | Curative (C) | 2017-03-21 | 2017-03-21 | CYTARABINE + MITOXANTRONE | N | null | 330021653 | ALEMTUZUMAB |
| 330013336 | 330005747 | 1.85 | null | null | 2020-01-13 | 2020-03-13 | Capecitabine + Cisplatin | 01 | N | 330023355 | LIPOSOMAL DAUNORUBICIN |
| 330013337 | 330002939 | 1.7 | 11.4 | Curative (C) | 2014-12-23 | 2015-06-24 | null | N | N | 330000050 | NOT MATCHED |
| 330013338 | 330007953 | 1.65 | 50.3 | Adjuvant (A) | 2018-07-03 | 2019-03-14 | Mifamurtide weeks 1-12 | N | N | 330005520 | MIFAMURTIDE |
| 330013339 | 330003666 | 1.63 | 51.2 | Curative (C) | 2019-01-05 | 2019-01-08 | Cetuximab 7 day (>Cycle 2) | N | N | 330005682 | CETUXIMAB |
| 330013340 | 330004132 | 0 | 55 | Palliative (P) | 2017-12-21 | 2017-12-28 | Docetaxel 75mg/m2 (21 day) | 2 | N | 330009031 | DOCETAXEL |
| 330013341 | 330004163 | null | 59 | Palliative (P) | 2018-04-20 | 2018-04-30 | Cyclophosphamide High Dose | N | null | 330009184 | CISPLATIN + ETOPOSIDE + PACLITAXEL |
| 330013342 | 330005215 | null | 58 | Disease modification (D) | 2020-05-20 | 2020-07-07 | Cyclophosphamide High Dose | N | N | 330017874 | TIP |
| 330013343 | 330005600 | 0.76 | null | Curative (C) | 2017-04-25 | 2017-05-03 | Gemcitabine weekly | N | N | 330021653 | ERLOTINIB |
| 330013344 | 330005747 | 0 | 118 | Palliative (P) | 2020-01-22 | 2020-03-13 | CETUXIMAB + CISPLATIN + FU | 01 | N | 330023355 | CYTARABINE |
| 330013345 | 330002940 | 1.65 | 58.4 | Adjuvant (A) | 2015-09-13 | 2015-09-16 | DOXORUBICIN | N | Y | 330000050 | DOXORUBICIN |
| 330013346 | 330010319 | null | 61.8 | Curative (C) | 2019-03-06 | 2019-03-14 | Temozolomide 150mg/m2 | N | N | 330005520 | VINBLASTINE |
| 330013347 | 330003667 | 1.26 | 18.5 | Curative (C) | 2017-07-02 | 2019-01-08 | Midostaurin | 02 | N | 330005682 | MIDOSTAURIN |
| 330013348 | 330011938 | 1.6 | 61 | Palliative (P) | 2017-07-31 | 2017-07-31 | Bortezomib + Panobinostat | N | null | 330021653 | VINCRISTINE |
| 330013349 | 330003635 | 1.59 | 97.5 | null | 2019-03-14 | 2019-03-26 | Paclitaxel 7 day | N | N | 330005520 | PACLITAXEL |
| 330013350 | 330003668 | 1.62 | 59 | Curative (C) | 2019-01-04 | 2019-01-08 | BENDAMUSTINE + RITUXIMAB | 02 | N | 330005682 | BENDAMUSTINE + RITUXIMAB |